News | News By Subject | News by Disease News By Date | Search News

Gastrointestinal Disorder (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Allergan (AGN) Takes Out GI Firm Motus in $200 Million Deal     10/28/2016
SoCal's Ionis Pharma (IONS) Cuts GI Deal Worth $810 Million With Janssen Biotech (JNJ)     7/19/2016
Shire (SHPG) Nabs Breakthrough Tags for Drug to Treat Rare Gastrointestinal Conditions     6/15/2016
Takeda (TKPYY), Theravance Biopharma (TBPH) Strike $125 Million Deal for TD-8954     6/8/2016
Rebiotix Receives Breakthrough Therapy Designation for RBX2660     10/12/2015
Sanofi (SNY) Terminates a $200 Million NaP2b Development Deal With Ardelyx (ARDX)     9/3/2015
Your Analyst-Vetted Guide to the Five Blockbuster Drugs the FDA May Approve This Summer     5/28/2015
RedHill Biopharma Ltd. (RDHL) Will Snag Small Molecule Rights from Apogee for $5.5M     3/31/2015
Synergy Pharmaceuticals May Be for Sale     3/27/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Isis Pharmaceuticals, Inc. (ISIS) Rockets as Johnson & Johnson (JNJ) Snags Bowel Drug License Option for $835 Million     1/7/2015
Pozen, Inc. (POZN) Crashes As FDA Rejects Two Forms Of Its Lead Drug Yosprala     12/18/2014
Johnson & Johnson (JNJ) Pulls Out Of Program To Develop Bowel Disease Drug     12/16/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014

News from Around the Web
Your Heartburn Drug Could Be Sending You To An Early Grave, BMJ Open Reveals     7/5/2017
First-Ever Autonomously Controlled 'Capsule Robot' Explores Colon, Vanderbilt University Medical Center Study Reveals     5/10/2017
Breaking The Cold Chain: New Vaccine Doesn't Need Refrigeration     3/23/2017
Cancer Detection 2017: Breath Test May Prove Useful In Sniffing Out Upper Gastrointestinal Cancer, Imperial College London Study Reveals     2/1/2017
Simple Mineral Could Be Cure For Complex Disease     11/11/2016
Can Season And Place Of Birth Influence Celiac Disease Risk? Umea University Study     8/17/2016
Genes Linked To People's Bowel Habits, Karolinska Institute Study     8/12/2016
New GI Dynamics (GID.AX) CEO Schorer Looks To Reboot EndoBarrier     5/25/2016
Chemical In Antibacterial Soap May Disrupt Mix Of Organisms In Digestive Tract, University of Tennessee Study     4/4/2016
Israeli Placental Cell Therapy Could Cure Radiation Sickness, Pluristem Therapeutics (PSTI) Reveals     3/10/2016
Regular Aspirin Use Cuts Overall Cancer Risk, Massachusetts General Hospital Study     3/4/2016
Tethered Capsule Detects GI Tract Disease, Harvard Medical School Study     2/26/2016
New Test May Improve Diagnosis And Treatment Of Pancreatobiliary And Other Gastrointestinal Cancers, University of Chicago Study     11/24/2015
Taking Probiotics Could Make You Less Stressed And Boost Your Memory, University College Cork Reveals     10/19/2015
The Irish Rugby Team Has Exceptional Guts, University College Cork And Teagasc Food Research Center Study     6/11/2014

Press Releases
Allergan (AGN) Reports New Data Reinforcing The Effectiveness Of Viberzi (Eluxadoline) To Treat The Symptoms Associated With Irritable Bowel Syndrome With Diarrhea (IBS-D), Abdominal Pain And Diarrhea     7/10/2017
BeiGene (BGNE) Presents Preliminary Phase I Data On BGB-A317 In Patients With Hepatocellular Carcinoma At The ESMO 19th World Congress On Gastrointestinal Cancer     6/29/2017
Founders Of Philadelphia Biotech Enterin Discover Link Between Upper GI Tract Infections And Parkinson's Disease     6/29/2017
Cincinnati Children's Hospital Medical Center Release: Lab Grown Human Colons Change Study Of GI Disease     6/23/2017
Leap Therapeutics Announces Collaboration With Merck & Co. (MRK) To Evaluate KEYTRUDA (Pembrolizumab) In Combination With DKN-01 In Esophagogastric Cancer     6/21/2017
Zealand Pharma  (ZEAL.CO) Release: Glepaglutide Meets Primary Endpoint In Phase II Trial In Patients With Short Bowel Syndrome     6/19/2017
Lexicon Pharma (LXRX) Release: NCCN Guidelines For Neuroendocrine Tumors Include XERMELO In Combination With Somatostatin Analog Therapy As A Recommended Treatment Option For Patients With Carcinoid Syndrome Diarrhea     6/19/2017
RedHill Biopharma (RDHL) To Host Conference Call On Successful Phase III Top-Line Results With BEKINDA For Acute Gastroenteritis     6/19/2017
RedHill Biopharma (RDHL) Announces Successful Phase III Top-Line Results With BEKINDA For Acute Gastroenteritis     6/15/2017
RedHill Biopharma (RDHL) Announces Successful Phase III Top-Line Results With BEKINDA For Acute Gastroenteritis     6/14/2017
Blueprint Medicines (BPMC) Announces New Phase I Clinical Data For BLU-285 In Advanced Gastrointestinal Stromal Tumors And Plans To Pursue Expedited Development In Patients With A PDGFRa D842V Mutation     6/5/2017
GENFIT (ALGFT): Positive Outcome From The 1-Year Pre-Planned Safety Review By The DSMB, In RESOLVE-IT Phase III Clinical Trial With Elafibranor     6/1/2017
Abeona Therapeutics Receives Regulatory Approval To Initiate Clinical Trial In Australia With ABO-102 Gene Therapy For Patients With MPS IIIA     5/9/2017
GENFIT (ALGFT): First Patient Enrolled In A Phase II Trial Recruiting Adults With Primary Biliary Cholangitis (PBC), A Rare Liver Disease     5/5/2017
Ritter Pharma Announces Issuance Of New Patents For Its Lactose Intolerance Treatment, RP-G28, And Provides An Update On Its Path Forward Into Phase III     5/3/2017

//-->